High Green News is coming at you from MJBizCon day two with another daily high five. The Thursday expo floor saw an impressive number of attendees, and we are here to share some of the booths you won’t want to miss on day three.
The highly anticipated MJBizCon is back once again at the Las Vegas Convention Center from Wednesday, December 11 to Friday, December 13. With 1,300 + exhibitors and 35,000 attendees, it is the largest gathering of cannabis business professionals in the world. This globally recognized B2B event is proving to be a success once again with the outstanding program of featured speakers and events that benefit every sector in the industry.
This year has been momentous for cannabis reform, from the Illinois General Assembly becoming the first state legislature to pass a bill to regulate cannabis like alcohol to the U.S. House of Representatives passing the SAFE Banking Act and forging ahead with the MORE Act.
It’s important to celebrate these victories, but with the end of 2019 comes the beginning of 2020, which is already shaping up to be the biggest year ever for marijuana-policy reform.
Florida's Supreme Court is considering an appeals court decision that would increase access to licenses for medical marijuana dispensaries in the state.
The decision would eliminate conservative requirements that force dispensaries to also own the means of production.
U.S. hemp sales could increase as much as $25 million in 2020 and by more than $100 million by 2022, according to new estimates by the U.S. Department of Agriculture (USDA).
These estimates are some of the figures outlined in Hemp Industry Daily’s new special report, “USDA Hemp Rules: A Handbook for Hemp & CBD Businesses.”
OTTAWA - Canadians spent about $908 million on non-medical cannabis in the first year since legalization, but online sales dropped as more brick-and-mortar locations opened, said Statistics Canada.
Canadians spent $907,833,000 on non-medical cannabis between October 2018 and September 2019, the agency said, which works out to $24 per capita.
Canada legalized cannabis on Oct. 17, 2018, becoming the second country in the world — after Uruguay — to legalize the drug. Demand initially appeared to outstrip supply as retailers warned of a pending shortfall of product.
In the announcement by ANVISA, the National Agency for Health Surveillance of Brazil, a new class of medical cannabis products will be prescribed by doctors and sold through pharmacies, enabling safe and legal patient access.
If you listen carefully, you will hear the sound of a crooked foundation known as marijuana prohibition starting to crumble in the United States. It has been more than eight decades since the federal government outlawed the cannabis plant nationwide, and yet, here we are finally standing on its lawn with torches in hand waiting for a day of reckoning.
With a marijuana legalization citizens’ initative barreling toward the 2020 ballot, yet another House panel will explore cannabis issues this week.
The Health Quality Subcommittee will hear Wednesday from out-of-state experts on public health concerns, potential trafficking issues, and “positive test results for cannabis in the workplace.”
The past year has been another strong year in cannabis. Investors continued to pour money into the burgeoning industry — surpassing 2018 investment totals in just 40 weeks — and new markets opened up for recreational and medical cannabis. And following the passage of the 2018 Farm Bill, CBD has proliferated and become one of the hottest health supplements in the country.
